Progranulin

Progranulin

Progranulin 詳細

Molecule Name
Progranulin
分子の別称
CLN11, GEP, GP88, PCDGF, PEPI, PGRN
Drug Development Progress
治験薬の数7
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
GRN
バックグランド
Progranulin, a secreted glycoprotein, is encoded in humans by the single GRN gene. Progranulin consists of seven and a half, tandemly repeated, non-identical copies of the 12 cysteine granulin motif. Many cellular processes and diseases are associated with this unique pleiotropic factor that include, but are not limited to, embryogenesis, tumorigenesis, inflammation, wound repair, neurodegeneration and lysosome function. Haploinsufficiency caused by autosomal dominant mutations within the GRN gene leads to frontotemporal lobar degeneration, a progressive neuronal atrophy that presents in patients as frontotemporal dementia.

Progranulin 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
GRN Gene Therapy(Eli Lilly And Company)PR-006; LY3884963Phase 2 ClinicalEli Lilly And Company
Frontotemporal Dementia
詳細
TAK-594DNL-593; PTV:PGRN; TAK-594Phase 2 ClinicalDenali Therapeutics Inc
Frontotemporal Dementia
詳細
AVB-101AVB-101Phase 2 ClinicalAviadoBio Ltd
Frontotemporal Dementia
詳細
NivisnebartAL-101; GSK-4527226Phase 2 ClinicalAlector Inc
Alzheimer Disease; Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Nerve Degeneration; Parkinson Disease
詳細
PBFT-02PBFT-02Phase 2 ClinicalUniversity Of Pennsylvania
Frontotemporal Dementia
詳細
VGN-R13VGN-R13Phase 1 ClinicalShanghai Vitalgen BioPharma Co Ltd
Amyotrophic Lateral Sclerosis
詳細
AG-01(A&G Pharm)AG-01(A&G Pharm)Phase 1 ClinicalA&G Pharmaceutical
Carcinoma, Non-Small-Cell Lung; Mesothelioma; Triple Negative Breast Neoplasms
詳細